Riskpilot← Back to searchSign inGet full accessM.B. PHARMOS A/S
A/SDissolvedCVR 18776405Ryvangs Allé 18Specialiseret engroshandel med fødevarer i.a.n. · NACE 463890Est. 19952-4 employees
Revenue 2018
DKK -790
+581% vs 2017
EBITDA margin
100.0%
-581% vs 2017
Equity ratio
100.0%
Financial strength
Net profit 2018
DKK 44K
+34% vs 2017
| Revenue | DKK -790 | +581% |
| EBITDA | DKK -790 | -581% |
| Net profit | DKK 44K | +34% |
| Total assets | DKK 2M | +2% |
| Equity | DKK 2M | +2% |
| Employees | — | — |
Legal name
M.B. PHARMOS A/S
CVR number
18776405
Legal form
Aktieselskab
NACE code
463890 · Specialiseret engroshandel med fødevarer i.a.n.
Founded
1. september 1995
Share capital
DKK 1.500.000
Employees
2-4
VAT registered
No
Audit selected
No
Last report
2018-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren eller 2 bestyrelsesmedlemmer i forening
Address
Ryvangs Allé 18
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | -803 | -310 | 26 | -21 | -25 | -0 | -1 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -803 | -310 | 26 | -21 | -25 | -0 | -1 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -803 | -310 | 26 | -21 | -25 | -0 | -1 |
| Net financials | 835 | 4 | 15 | 66 | 61 | 42 | 44 |
| Profit before tax | 31 | -306 | 40 | 45 | 36 | 42 | 44 |
| Tax | 8 | -77 | 10 | 10 | 11 | 9 | -1 |
| Net profit | 24 | -230 | 31 | 34 | 25 | 33 | 44 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|---|
| Total assets | 2.222 | 1.832 | 1.829 | 1.878 | 1.898 | 1.912 | 1.954 |
| Equity | 2.118 | 1.788 | 1.818 | 1.853 | 1.877 | 1.910 | 1.954 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 104 | 44 | 10 | 26 | 20 | 1 | 0 |
| Total debt | 104 | 44 | 10 | 26 | 20 | 1 | 0 |
EBITDA margin
-79000.0%
This company
15.8%
Market median
-500100% vs market
20122018
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20122018
Return on equity
2.3%
This company
18.4%
Market median
-88% vs market
20122018
Net profit margin
4412100.0%
This company
8.1%
Market median
+54470270% vs market
20122018
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20122018
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20122018
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Audit | 2002 | — | — | |
ET | Audit | 1995 | — | — |
HO Management | Management | 1999 | — | — |
JB Management | Management | 1999 | — | — |
AH Chief Executive Officer | Chief Executive Officer | 2002 | — | — |
BU Management | Management | 2002 | — | — |
PE Management | Management | 1995 | — | — |
LH Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2002 | — | — | |
| Board of Directors | 1995 | — | — | |
| Chairman | 2002 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2000 | — | — | |
| Board of Directors | 1995 | — | — | |
| Board of Directors | 1997 | — | — | |
| Board of Directors | 1999 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2014 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ORDRUPHØJ INVEST I ApS | Company | 100.0% | 100.0% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of M.B. PHARMOS A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Helge Steffensen Skelhøj | Audit | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Hans Ole Svendsen | Management | 0 companies |
| Jesper Breuning-Hansen | Management | 0 companies |
| Annette Helene Schacht | Chief Executive Officer | 0 companies |
| Birgitte Ulrich Høyer | Management | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Laurits Henning Lauritsen | Chief Executive Officer | 0 companies |
| Christian Frederik Høyer | Board of Directors | 0 companies |
| Anette Breuning-Hansen | Board of Directors | 0 companies |
| Johannes Fausbøll Mosbech | Chairman | 0 companies |
| Susanne Lauritsen | Board of Directors | 0 companies |
| Hans Henrik Raith | Chairman | 0 companies |
| Margrethe Mosbech | Board of Directors | 0 companies |
| Juhani Paloluoma | Board of Directors | 0 companies |
| Holger Fausbøll Mosbech | Board of Directors | 0 companies |
| Jonas Hammershaimb Mosbech | Board of Directors | 0 companies |
| Pernille Ulrich Berthelsen | Board of Directors | 0 companies |